Ever Source Wealth Advisors, LLC Aclaris Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 458 shares of ACRS stock, worth $938. This represents 0.0% of its overall portfolio holdings.
Number of Shares
458Holding current value
$938% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACRS
# of Institutions
99Shares Held
87.6MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN14.3MShares$29.2 Million15.31% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$19.7 Million0.02% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$18.2 Million2.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.66MShares$13.7 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.77MShares$9.78 Million0.46% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $137M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...